Antimicrobial dosages for adults with impaired kidney function: R
This table gives dosing recommendations for adults with impaired kidney function. For antimicrobial dosing in children with impaired kidney function, seek expert advice.
raltegravir | |
Dosage adjustment based on GFR [NB2] | |
more than 50 mL/min |
normal |
10 to 50 mL/min |
normal |
less than 10 mL/min |
normal |
Dosages for dialysis | |
intermittent haemodialysis |
no data |
peritoneal dialysis |
no data |
continuous renal replacement therapy |
no data |
rifabutin | |
Dosage adjustment based on GFR [NB2] | |
more than 50 mL/min |
normal |
10 to 50 mL/min |
normal |
less than 10 mL/min |
normal |
Dosages for dialysis [NB2] | |
intermittent haemodialysis |
normal |
peritoneal dialysis |
normal |
continuous renal replacement therapy |
normal |
rifampicin | |
Dosage adjustment based on GFR [NB2] [NB3] | |
more than 50 mL/min |
normal |
10 to 50 mL/min |
normal |
less than 10 mL/min |
50 to 100% at normal dosing interval |
Dosages for dialysis | |
intermittent haemodialysis |
as for GFR less than 10 mL/min |
peritoneal dialysis | |
continuous renal replacement therapy | |
rifapentine | |
Dosage adjustment based on GFR [NB2] | |
more than 50 mL/min |
normal |
10 to 50 mL/min |
normal |
less than 10 mL/min |
normal [NB4] |
Dosages for dialysis [NB2] | |
intermittent haemodialysis |
normal [NB4] |
peritoneal dialysis |
normal [NB4] |
continuous renal replacement therapy |
normal [NB4] |
rifaximin | |
Dosage adjustment based on GFR [NB2] | |
more than 50 mL/min |
normal |
10 to 50 mL/min |
normal |
less than 10 mL/min |
normal |
Dosages for dialysis [NB2] | |
intermittent haemodialysis |
normal |
peritoneal dialysis |
normal |
continuous renal replacement therapy |
normal |
rilpivirine | |
Dosage adjustment based on GFR [NB2] | |
more than 50 mL/min |
normal |
10 to 50 mL/min |
normal |
less than 10 mL/min |
normal |
Dosages for dialysis [NB2] | |
intermittent haemodialysis |
normal |
peritoneal dialysis |
normal |
continuous renal replacement therapy |
normal |
ritonavir | |
Dosage adjustment based on GFR [NB2] | |
more than 50 mL/min |
normal |
10 to 50 mL/min |
normal |
less than 10 mL/min |
normal |
Dosages for dialysis [NB2] | |
intermittent haemodialysis |
normal |
peritoneal dialysis |
normal |
continuous renal replacement therapy |
normal |
Note:
GFR = glomerular filtration rate NB1: Dosing in patients with kidney impairment is complex. This table is intended as a guide only, see General considerations for antimicrobial dosage modification in kidney impairment. If relevant, see Dialysis and continuous renal replacement therapy for further guidance on using this table. NB2: ‘Normal’ indicates that the standard dosage regimen for the specific indication in these guidelines should be used. NB3: For multiple-daily doses, percentage dosage adjustments are calculated using the intermittent dose rather than the total daily dose (eg if standard dosing for drug X is 500 mg 6-hourly, then 50% at normal dosing interval = 250 mg 6-hourly, and 100% 12-hourly = 500 mg 12-hourly). NB4: In patients undergoing dialysis, there is an increased incidence of rifapentine related adverse effects. Rifapentine may be used at the normal dosage for the treatment of latent tuberculosis but close monitoring for adverse effects is requiredLin 2019Lin 2021. |